Amgen beats Street

Amgen Inc. (NASDAQ:AMGN) reported 1Q11 adjusted diluted EPS of $1.34, beating by $0.05 the Street's estimate of $1.29 and up 3% from $1.30 in 1Q10. First quarter revenues were $3.71 billion, up 3% from $3.59 billion in 1Q10 and above the Street's estimate of $3.68 billion. ...